Good Neighbor Pharmacy ranks #1 in JD Power customer satisfaction

2 min read     Updated on 30 Jul 2026, 02:09 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Good Neighbor Pharmacy achieved the #1 spot in customer satisfaction in the 2026 JD Power U.S. Pharmacy Study, marking its 14th win in 17 years. The franchise, part of Cencora, also topped four key dimensions including trust and convenience. The announcement coincided with ThoughtSpot, Cencora’s annual conference, which also recognized three pharmacies with Champion Awards for their contributions to advocacy and clinical care.

powered bylight_fuzz_icon
46903166

*this image is generated using AI for illustrative purposes only.

Good Neighbor Pharmacy, a national franchise for independent pharmacies offered through Cencora, has been ranked number one in customer satisfaction with chain drug store pharmacies in the 2026 JD Power U.S. Pharmacy Study. The recognition highlights the brand’s sustained performance in a competitive sector where patient trust and service convenience are critical differentiators for community care providers. This ranking coincides with ThoughtSpot, Cencora’s flagship annual tradeshow and conference for community care providers, which gathered more than 4,000 pharmacy owners, industry experts, and partners.

The JD Power study is a syndicated benchmarking profile of customer experiences at the largest pharmacies in the United States. In addition to achieving the highest overall score, Good Neighbor Pharmacy ranked highest across four of the seven evaluated dimensions. These categories include pharmacy offerings meeting needs for medication and health and wellness services, convenience in obtaining prescriptions, staff interactions, and overall trust levels with the pharmacy.

Historical Performance

This latest accolade represents the 14th time Good Neighbor Pharmacy has earned this top recognition in the last 17 years. The brand previously received the highest scores among chain drug store pharmacies in the JD Power U.S. Pharmacy Studies conducted in 2010, 2011, 2013, 2014, 2015, 2017, 2018, 2019, 2020, 2021, 2022, 2023, and 2024. The consistency of these results underscores a long-term strategy focused on community engagement and operational reliability.

Dimension Ranking
Overall Customer Satisfaction #1
Pharmacy Offerings (Medication & Wellness) #1
Convenience (Prescription Access) #1
Staff Interactions #1
Trust with Pharmacy #1

Industry Recognition and Awards

The announcement was made during ThoughtSpot, Cencora’s 15th annual event designed to equip community care providers with strategies to increase efficiency and grow revenue. Tim Cernohous, SVP and President of Community Retail and Long-Term Care Pharmacy at Cencora, stated that the JD Power recognition reflects the daily impact community pharmacies make and belongs to the members for their commitment to serving their communities.

During the event, the 2026 Good Neighbor Pharmacy Champion Awards were unveiled on July 28, spotlighting three pharmacies for outstanding contributions in advocacy, clinical care, and storytelling:

  • Moreland & Devitt Pharmacy in West Central Illinois, led by CEO and pharmacist Scott Stoll.
  • Desert Hospital Outpatient Pharmacy in Palm Springs, California, led by CEO Ramesh Upadhyayula.
  • Quik-Stop Pharmacy in Thorndale, Pennsylvania, led by president and pharmacist Alissa Griffith.

Kenzie Hohman, NVP of Community Pharmacy Solutions at Cencora, noted that these recipients exemplify leadership in independent pharmacy, whether through policy advocacy, clinical service delivery, or building trust within their communities. The event also introduced a dedicated experience for medically integrated dispensing and specialty dispensing practices for the first time, offering targeted education for program managers and pharmacists.

How might Good Neighbor Pharmacy's #1 customer satisfaction ranking influence Cencora's valuation and competitive positioning against larger pharmacy chains in the coming fiscal year?

What specific operational strategies or technology integrations discussed at ThoughtSpot are expected to help independent pharmacies maintain these high satisfaction scores amidst rising labor costs?

Will the introduction of dedicated education for medically integrated and specialty dispensing practices signal a broader shift in revenue models for community pharmacies away from traditional dispensing fees?

like17
dislike

Cencora announces Q3 FY26 earnings release date

1 min read     Updated on 02 Jul 2026, 04:13 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Cencora, Inc. has scheduled the release of its third quarter fiscal 2026 financial results for August 5, 2026, before the market opens. A conference call featuring CEO Robert P. Mauch and CFO Eva C. Boratto will follow at 8:30 a.m. ET to discuss the performance. Investors can access the call via telephone or a live webcast on the company's website.

powered bylight_fuzz_icon
44491387

*this image is generated using AI for illustrative purposes only.

Cencora, Inc. will release its financial results for the third quarter of fiscal 2026 on August 5, 2026, prior to the opening of trading on the New York Stock Exchange. The company will host a conference call to discuss the results at 8:30 a.m. ET on August 5, 2026. This announcement provides investors with the timeline for accessing the upcoming quarterly performance data.

Conference Call Details

Participating in the conference call will be Robert P. Mauch, President & Chief Executive Officer, and Eva C. Boratto, Executive Vice President & Chief Financial Officer. The live call will be webcast via the company’s website at investor.cencora.com. Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time.

Access Information

To access the call via telephone from within the United States and Canada, dial +1 (833) 461-5787. From outside the United States and Canada, dial +1 (585) 542-9983. The meeting ID for the call will be 632 369 927.

Access Method Details
US/Canada Dial-in +1 (833) 461-5787
International Dial-in +1 (585) 542-9983
Meeting ID 632 369 927
Webcast Link investor.cencora.com

Replay Availability

A replay of the webcast will be posted on investor.cencora.com approximately one hour after the completion of the call and will remain available for one year. Investors are advised to check the website for updates regarding the timing of the live webcasts and for replay information.

What key performance indicators will investors focus on during the Q3 fiscal 2026 earnings call?

How might Cencora's Q3 results impact its stock price and investor sentiment?

What strategic initiatives or market trends could influence Cencora's financial performance in the upcoming quarters?

like18
dislike

More News on Cencora Inc